Skip to content

Clinical trials

Mucopolysaccharidosis IV trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis IV Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20083
20093
20103
20114
20127
20136
20144
20152
20163
20172
20186
20196
20207
20217
20226
20238
20244
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting18
Terminated10
Unknown status9
Enrolling by invitation4
Active, not recruiting4
Withdrawn2
Not yet recruiting2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical11
QED Therapeutics, a BridgeBio company8
University of California, San Francisco3
CENTOGENE GmbH Rostock2
Emory University2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Nadia Ali, PhD2
Pfizer2
Regeneron Pharmaceuticals2
State Key Laboratory of Respiratory Disease2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis IV100
Dwarfism12
Mucopolysaccharidosis VI12
Lysosomal Storage Diseases11
Bone Diseases10
Diarrhea10
Genetic Diseases, Inborn10
Osteochondrodysplasias10
Constipation9
Musculoskeletal Diseases9

Trials

Showing 26 to 50 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.